Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Chapuis

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Cancer Research|August 12, 2010
Insulin receptor A and IGF-1R in AML - LetterNicolas Chapuis, Catherine Lacombe, Jerome Tamburini, et al.
Frontiers in Oncology|June 14, 2019
Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid LeukemiaNicolas Chapuis, Laury Poulain, Rudy Birsen, et al.
Intensive Care Medicine|March 10, 2021
Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesisLee S Nguyen, Zakaria Ait Hamou, Nabil Gastli, et al.
Current Oncology Reports|February 22, 2012
PI3K and mTOR signaling pathways in cancer: new data on targeted therapiesLise Willems, Jerome Tamburini, Nicolas Chapuis, et al.
Cell Cycle (Georgetown, Tex.)|May 17, 2011
LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biologyAlexa S Green, Nicolas Chapuis, Catherine Lacombe, et al.
Cell Cycle (Georgetown, Tex.)|November 26, 2009
Targeting translation in acute myeloid leukemia: a new paradigm for therapy?Jerome Tamburini, Alexa S Green, Nicolas Chapuis, et al.
The Annals of Thoracic Surgery|August 14, 2019
Paraneoplastic Hyperleukocytosis Mimicking Hematologic Malignancy Revealing a Localized Lung CancerAmira Marouf, Nicolas Chapuis, Anne Sophie Alary, et al.
Leukemia Research|July 20, 2018
Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cellsKiyoyuki Ogata, Kazuma Sei, Leonie Saft, et al.
Anti-Cancer Drugs|March 17, 2012
A dramatic fetal outcome following transplacental transfer of dasatinibPaul Berveiller, Annalisa Andreoli, Olivier Mir, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2022
Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosisClara Vigneron, Valentine Le Stang, Justine Decroocq, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Cancer Research|August 12, 2010
Insulin receptor A and IGF-1R in AML - LetterNicolas Chapuis, Catherine Lacombe, Jerome Tamburini, et al.
Frontiers in Oncology|June 14, 2019
Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid LeukemiaNicolas Chapuis, Laury Poulain, Rudy Birsen, et al.
Intensive Care Medicine|March 10, 2021
Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesisLee S Nguyen, Zakaria Ait Hamou, Nabil Gastli, et al.
Current Oncology Reports|February 22, 2012
PI3K and mTOR signaling pathways in cancer: new data on targeted therapiesLise Willems, Jerome Tamburini, Nicolas Chapuis, et al.
Cell Cycle (Georgetown, Tex.)|May 17, 2011
LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biologyAlexa S Green, Nicolas Chapuis, Catherine Lacombe, et al.
Cell Cycle (Georgetown, Tex.)|November 26, 2009
Targeting translation in acute myeloid leukemia: a new paradigm for therapy?Jerome Tamburini, Alexa S Green, Nicolas Chapuis, et al.
The Annals of Thoracic Surgery|August 14, 2019
Paraneoplastic Hyperleukocytosis Mimicking Hematologic Malignancy Revealing a Localized Lung CancerAmira Marouf, Nicolas Chapuis, Anne Sophie Alary, et al.
Leukemia Research|July 20, 2018
Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cellsKiyoyuki Ogata, Kazuma Sei, Leonie Saft, et al.
Anti-Cancer Drugs|March 17, 2012
A dramatic fetal outcome following transplacental transfer of dasatinibPaul Berveiller, Annalisa Andreoli, Olivier Mir, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2022
Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosisClara Vigneron, Valentine Le Stang, Justine Decroocq, et al.
Pageof 10